Skip to content
My WebMD Sign In, Sign Up
Font Size

Common Diabetes Drug May Fight Cancer

Metformin Shows Preliminary Promise Against Prostate, Pancreatic Tumors

Metformin vs. Pancreatic Cancer

Researchers at the University of Texas M.D. Anderson Cancer Center in Houston examined the records of 302 people with pancreatic cancer and diabetes; 117 were taking metformin.

Results showed that 30% of those taking metformin were alive at two years vs. 15% of those who weren’t taking the diabetes drug.

Also, people on metformin lived an average of 15 months vs. 11 months for those who didn't take the drug.

The study doesn't prove that metformin made the difference. People who took the drug might have other advantages that weren't measured.

More study of metformin in these and other cancers is planned. If it does pan out, one plus could be price. While new cancer drugs can cost thousands of dollars a dose, a month's supply of metformin is typically $30 to $50.

These findings were presented at a medical conference. They should be considered preliminary, as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.

1|2

Today on WebMD

Prostate Cancer Overview
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
woman speaking with doctor
VIDEO
Prostate Nerve Transplant
VIDEO
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW